Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Inflammation in Alzheimer's Disease, and Prevention with Antioxidants and Phenolic Compounds – What Are the Most Promising Candidates?

    Access Status
    Fulltext not available
    Authors
    Sharman, M.
    Verdile, Giuseppe
    Kirubakaran, S.
    Münch, G.
    Date
    2019
    Type
    Book Chapter
    
    Metadata
    Show full item record
    Source Title
    Neurodegeneration and Alzheimer's Disease: The Role of Diabetes, Genetics, Hormones, and Lifestyle
    DOI
    10.1002/9781119356752.ch8
    Faculty
    Faculty of Health Sciences
    School
    School of Pharmacy and Biomedical Sciences
    URI
    http://hdl.handle.net/20.500.11937/75632
    Collection
    • Curtin Research Publications
    Abstract

    Early studies of Alzheimer's disease (AD) revealed key neurological features including the deposition of aggregates of insoluble β‐amyloid (Aβ) peptides, the formation of neurofibrillary tangles (NFT), and signs of chronic inflammation. The initial forms of these pathological hallmarks of the disease, including small oligomers of Aβ peptides and the hyperphosphorylated tau which aggregates into NFT, have been assumed to be part of ‘the cause of AD’ and have been specifically targeted to develop an effective monotherapy, but with limited success. In the absence of effective neuroprotective drugs, acetylcholinesterase inhibitors have remained as the drug class that is most used to treat AD, yet they cannot and do not slow the progression of the disease. Imaging studies have confirmed what has long been suspected – that there is a very long pre‐clinical phase, when pathology gradually builds up, possibly starting with chronic inflammation, oxidative stress, and dysregulated metabolism. Emerging therapies are targeted more towards these changes, sometimes as well as the Aβ and NFT pathologies in multi‐targeted approaches, to interfere with the pathological cascades in AD. The aim is to prevent, stop, or at least slow the neurodegeneration before debilitating symptoms appear. This chapter summarises inflammatory and oxidative stress‐related changes that occur in AD, and discusses some emerging therapies and supplements, particularly those directed at inflammation, that may slow pathogenesis of this complex neurodegenerative disease.

    Related items

    Showing items related by title, author, creator and subject.

    • Nutritional and pharmacological regulation of cerebral capillary function
      Pallebage-Gamarallage, Menuka Madhavi Somapala (2012)
      Alzheimer’s disease (AD) is the most common cause of dementia pathologically characterised by neurovascular inflammation, extracellular proteinaceous deposits enriched in amyloid-β (Aβ) and formation of neurofibrillar ...
    • TWEAK and LTß Signaling during Chronic Liver Disease
      Dwyer, Benjamin; Olynyk, John; Ramm, G.; Tirnitz-Parker, Nina (2014)
      Chronic liver diseases (CLD) such as hepatitis B and C virus infection, alcoholic liver disease, and non-alcoholic steatohepatitis are associated with hepatocellular necrosis, continual inflammation, and hepatic fibrosis. ...
    • Nicotine Attenuates Disruption of Blood-Brain Barrier Induced by Saturated-Fat Feeding in Wild-Type Mice.
      Elahy, M.; Lam, V.; Pallebage-Gamarallage, M.; Giles, C.; Mamo, John; Takechi, R. (2015)
      INTRODUCTION: Emerging evidence suggests that integrity of blood-brain barrier (BBB) is pivotal to pathology and pathogenesis of vascular-based neurodegenerative disorders. We have recently reported BBB protective effects ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.